精确表观遗传学为改善全球冠心病护理提供了一个可扩展的途径
Damon Broyles1,2, Robert Philibert3,4,5
1Mercy Technology Services, St. Louis, MO 63127, USA.
Epigenomics
|September 13, 2023
概括
预防冠心病 (CHD) 死亡需要更好的诊断工具. 与人工智能相结合的DNA甲基化测试为全球性心血管疾病评估和治疗监测提供了可扩展,精确的解决方案.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 生物技术是生物技术.
背景情况:
- 冠心病 (CHD) 仍然是全球主要的死亡原因.
- 目前的CHD诊断方法面临实施挑战,特别是在资源有限的环境中.
- 需要可扩展和精确的方法来评估CHD和监测治疗.
研究的目的:
- 审查与心脏病相关的DNA甲基化现有研究.
- 探索将甲基化数据与其他生物变量结合用于心脏病诊断的潜力.
- 为了比较基于甲基化的新方法与已建立的CHD诊断技术.
主要方法:
- 关于DNA甲基化和心脏病的研究的文献综述.
- 对联合甲基化和生物可变数据的分析.
- 对新型与传统心脏病诊断方法的比较评估.
主要成果:
- 基因甲基化测试,特别是人工智能测试,显示出可扩展性心血管疾病评估的前景.
- 基于甲基化的方法有可能克服当前诊断工具的障碍.
- 与其他生物变量集成可能会提高诊断精度.
结论:
- DNA甲基化测试代表了CHD诊断的重大进步.
- 这些方法为全球民主化改进的CHD评估提供了一条途径.
- 基于人工智能的甲基化分析可以提高心血管疾病管理的精度和可扩展性.
相关概念视频
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12


